Edition:
United States

Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

98.82USD
11:49am EDT
Change (% chg)

$1.30 (+1.34%)
Prev Close
$97.51
Open
$98.36
Day's High
$99.40
Day's Low
$97.86
Volume
34,249
Avg. Vol
172,634
52-wk High
$125.83
52-wk Low
$86.55

Latest Key Developments (Source: Significant Developments)

Core Lab reports qtrly earnings per share $0.52
Monday, 24 Jul 2017 07:01pm EDT 

July 24 (Reuters) - Core Laboratories NV :Core Lab reports second quarter 2017 results:.Core Laboratories NV - Q2 2017 revenue of $164 million , up 4% sequentially from its Q1 2017 revenue.Qtrly earnings per share $0.52.Company projects that its operating income in Q3 is expected to range between $30.9 million and $33.5 million.EPS for Q3 is expected to range between $0.54 and $0.56..Q3 earnings per share view $0.61 -- Thomson Reuters I/B/E/S.Core Laboratories NV - Core projects Q3 2017 revenue of approximately $166 million to $170 million.Q3 revenue view $179.5 million -- Thomson Reuters I/B/E/S.  Full Article

Core Laboratories Q2 profit of 52 cents/shr
Monday, 24 Jul 2017 05:15pm EDT 

July 24 (Reuters) - Core Laboratories Nv ::Core Laboratories NV - q2 2017 revenue of $163.9 million, up 4 pct sequentially from its q1 2017 revenue.Core Laboratories NV qtrly earnings per diluted share of $0.51.Core Laboratories NV qtrly ex-fx eps of $0.52.Core Laboratories - core projects q3 2017 revenue of approximately $165.5 million to $170 million.Core Laboratories - projects operating income in q3 is expected to range between $30.9 million and $33.5 million.Core Laboratories nv - eps for q3 is expected to range between $0.54 and $0.56.Core Laboratories - q3 2017 fcf is expected to exceed net income.Q2 earnings per share view $0.51, revenue view $168.5 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.61, revenue view $179.5 million -- Thomson Reuters I/B/E/S.  Full Article

Core Lab says Q1 EPS of $0.40
Wednesday, 19 Apr 2017 04:47pm EDT 

April 19 (Reuters) - Core Laboratories NV ::Core Lab reports first quarter 2017 results:.Core Laboratories nv says q1 gaap eps of $0.40, q1 ex-items eps of $0.42.Qtrly revenue of $158 million, up more than 5 pct sequentially from 4q 2016.Sees q2 2017 earnings per share $0.48 to $0.52.Sees q2 2017 revenue about $165 million to $170 million.Q1 earnings per share view $0.39, revenue view $150.2 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.48, revenue view $160.5 million -- Thomson Reuters I/B/E/S.Core anticipates reactivating its share repurchase program during q2.  Full Article

Core Laboratories CEO David Demshur's 2016 total compensation was $6.2 mln
Friday, 24 Mar 2017 04:09pm EDT 

Core Laboratories Nv - :CEO David Demshur's fy 2016 total compensation was $6.2 million versus $6.6 million in fy 2015 - sec filing.  Full Article

Core Lab reports Q4 earnings per share $0.35
Wednesday, 25 Jan 2017 04:15pm EST 

Core Laboratories Nv - : Core Lab reports fourth quarter 2016 results: . Q4 gaap earnings per share $0.35 . Q4 revenue $150 million . Sees Q1 2017 gaap earnings per share $0.38 . Q4 earnings per share view $0.40, revenue view $145.5 million -- Thomson Reuters I/B/E/S . Q1 earnings per share view $0.42 -- Thomson Reuters I/B/E/S .Quarterly ex-items eps of $0.41.  Full Article

Core Laboratories reports Q4 earnings per share $0.35
Wednesday, 25 Jan 2017 04:06pm EST 

Core Laboratories Nv : Qtrly earnings per share $0.35 . Qtrly adjusted earnings per share $0.41 . Q4 2016 revenue of $149.5 million up over 4% sequentially from Q3 2016 . Q4 earnings per share view $0.40, revenue view $145.5 million -- Thomson Reuters I/B/E/S . On a GAAP basis, core has projected eps for q1 of 2017 to be $0.38 .Q1 earnings per share view $0.42 -- Thomson Reuters I/B/E/S.  Full Article

Core Laboratories N.V. Q2 revenue of $148.1 mln decreased 3.6 pct sequentially
Wednesday, 20 Jul 2016 04:08pm EDT 

Core Laboratories N.V. : Second quarter EPS of $0.38 GAAP; EPS of $0.35, excluding items . At current activity levels, core predicts 2016 U.S. onshore oil production will fall approximately 1,100,000 bopd . Second quarter revenue of $148.1 million decreased 3.6 pct sequentially .Q2 earnings per share view $0.35, revenue view $146.4 million -- Thomson Reuters I/B/E/S.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Wednesday, 11 May 2016 08:48pm EDT 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Wednesday, 11 May 2016 07:59pm EDT 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core laboratories NV files for stock shelf of up to 1.3 mln shares
Wednesday, 11 May 2016 06:14pm EDT 

Core Laboratories NV :Core Laboratories NV files for stock shelf of up to 1.3 million shares of common stock - SEC Filing.  Full Article

BRIEF-Core Laboratories Q2 profit of 52 cents/shr

* Core Laboratories NV - q2 2017 revenue of $163.9 million, up 4 pct sequentially from its q1 2017 revenue